Data / Form D filings / ESTRIGENIX THERAPEUTICS, INC.
ESTRIGENIX THERAPEUTICS, INC.: Form D filing
ESTRIGENIX THERAPEUTICS, INC., a pharmaceuticals company in Wauwatosa, WI, filed a Form D with the SEC in 2026. The latest, on July 27, 2026, reports $1 million sold of a $2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1225 DISCOVERY PKWY UNIT 255C, Wauwatosa, WI, 53226
- Phone
- (262) 409-1484
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2141466
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 1 | Jul 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Sem | Executive Officer, Director | |
| William Donaldson | Executive Officer, Director | |
| Karyn Frick | Executive Officer | |
| Patricia Scheller | Director | |
| Victoria Zellmer | Executive Officer |
Every Form D from the week of Jul 27, 2026 · All recent filings in Wisconsin · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ESTRIGENIX THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.